We are an innovative science-led orthomolecular healthcare company focused on developing safe and effective virus agnostic treatment models that will revolutionise the way we protect ourselves against the Coronavirus.
Today, most of the COVID-19 developments are either in finding a pathogen-specific preventative solution (vaccine) or a therapeutic one (antibodies, antivirals). The global unavailability of a vaccine for coronavirus, uncertainty around its route of administration, doubts about its efficacy, the possible requirement of booster doses, and the duration of immunity remain challenges.
With the rapid spread of the virus around the world, we need a different alternative. This led to our founder James Lindberg thinking differently about taming the virus, creating the start of Covimro.